Adolescents and young adults are recommended to receive 9vHPV vaccine from 9 years of age

Adolescents and young adults are recommended to receive 9vHPV vaccine from 9 years of age and onwards. The optimal age for HPV vaccination is around 12–13 years prior to exposure to HPV. People who have not received HPV vaccine by 14 years of age can still receive the vaccine up to 25 years of age. However vaccination is most effective if the vaccine is given early in adolescence.

The recommended schedule for adolescents and young adults aged 9–25 years is 1 dose.^1-4

People with severely immunocompromising conditions need 3 doses of HPV vaccine, regardless of their age (see Vaccination for people who are immunocompromised).

Women who have received HPV vaccine are recommended to undergo cervical screening through the National Cervical Screening Program according to the Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding.⁵  HPV types other than those included in the HPV vaccines can cause cervical cancer. Therefore, both cervical screening and HPV vaccination are recommended.